Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa

NCT04975178 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

7120

Enrollment

INDUSTRY

Sponsor class

Conditions

Tuberculosis

Interventions

BIOLOGICAL: MTBVAC
BIOLOGICAL: BCG

Sponsor

Biofabri, S.L

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]